HIGHLIGHTS
- who: Small-molecule PROTAC mediates et al. from the Institut Shanghai University, Shanghai, China have published the article: Authorship note: JJ, Yaping Wu, and Z. Zhao contributed equally to this work. Conflict of interest: The authors have declared that no conflict of interest exists, in the Journal: (JOURNAL) of October/11,/2022
- what: This study demonstrated the potential of TSM-1, a TSN-based heterobifunctional PROTAC molecule, to knock down STAT3 protein expression both in_vitro and in_vivo.
- how: These results showed that TSM-1 inhibited the viability of HNSCC and CRC cells . The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.